ERCC1 and cancer: Finally, the finding that patients with 2–3 ERCC1 risk genotypes had increased risk of having early-stage cancer may suggest that the observed risk could be genetic susceptibility as the cause for carcinogenesis of the target tissue rather than tumor progression that could be driven by additional mutational events [34].